The store will not work correctly when cookies are disabled.
3-(3-fluorophenyl)-2-(8-hydroxyquinolin-2-yl)thiazolidin-4-one
ID: ALA4740594
PubChem CID: 162645167
Max Phase: Preclinical
Molecular Formula: C18H13FN2O2S
Molecular Weight: 340.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CSC(c2ccc3cccc(O)c3n2)N1c1cccc(F)c1
Standard InChI: InChI=1S/C18H13FN2O2S/c19-12-4-2-5-13(9-12)21-16(23)10-24-18(21)14-8-7-11-3-1-6-15(22)17(11)20-14/h1-9,18,22H,10H2
Standard InChI Key: MKNALTUFJWJGRJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
27.8450 -9.9672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8439 -10.7868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5519 -11.1957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5501 -9.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2587 -9.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2595 -10.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9680 -11.1897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6763 -10.7789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6715 -9.9567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9624 -9.5534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5538 -12.0129 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3897 -11.1819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4783 -11.9942 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2783 -12.1610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6842 -11.4517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1350 -10.8466 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.8748 -12.5409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0960 -12.2898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4912 -12.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6640 -13.6378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4470 -13.8861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0484 -13.3360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6136 -12.9063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6228 -14.6841 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
8 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
14 23 2 0
21 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.38 | Molecular Weight (Monoisotopic): 340.0682 | AlogP: 3.86 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 3.41 | CX LogD: 3.40 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.77 | Np Likeness Score: -1.14 |
References
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |